$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
艾乐替尼医保能报销吗?
2025-10-19 11:44:20
Check Details
艾乐替尼一个月费用
2025-10-19 11:44:20
Check Details
肺癌靶向药艾乐替尼效果如何?
2025-10-19 11:44:20
Check Details
靶向药艾乐替尼怎么购买?
2025-10-19 11:44:20
Check Details
靶向药艾乐替尼售价多少?
2025-10-19 11:44:20
Check Details
艾乐替尼功效与作用
2025-10-19 11:44:20
Check Details
艾乐替尼口服说明书
2025-10-19 11:44:20
Check Details
艾乐替尼国内有吗?
2025-10-19 11:44:20
Check Details
艾乐替尼一般多久会耐药?
2025-10-19 11:44:20
Check Details
一线治疗ALK非小细胞肺癌,劳拉替尼优于克唑替尼
2025-10-19 11:44:20
Check Details
Capmatinib(卡马替尼)对MET外显子14跳跃突变的晚期NSCLC具有活性
2025-10-19 11:44:20
Check Details
Pralsetinib和Selpercatinib扩展了治疗RET+NSCLC模式
2025-10-19 11:44:20
Check Details
1
2
...
3634
3635
3636
3637
3638
3639
3640
...
4153
4154
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Complete Guide to Dosage and Dose Adjustment of Entrectinib
2
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
3
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
4
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
5
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
6
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
7
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
8
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
9
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
10
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
11
Cemiplimab (Libtayo) Drug Information
12
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer